Log in to your Inderes Free account to see all free content on this page.
Bioretec
0.15 EUR
-4.92 %
1,715 following
Corporate customer
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-4.92 %
-62.95 %
-74.25 %
-77.01 %
-88.68 %
-93.31 %
-93.11 %
-
-94.51 %
Bioretec operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other materials for bone and soft tissue injuries. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic region.
Read moreMarket cap
4.76M EUR
Turnover
44.75K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Latest research
Latest analysis report
Released: 16.02.2026
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.3.
2026
Extraordinary general meeting '26
8.5.
2026
General meeting '26
14.5.
2026
Business review Q1'26
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Inside information: Timo Lehtonen takes on a new role at Bioretec as External Executive Advisor and steps down from the management team
Bioretec is planning rights issue worth 5-15 MEUR
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
